Seungho Lee

Seungho Lee

Auto-generated profile, based on publicly available information

Seungho Lee

Department of Surgery, Yonsei University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
YKYounggwang Kim
Younggwang Kim
HOHyeong-Cheol Oh
Hyeong-Cheol Oh
SLSeungho Lee
Seungho Lee
HKHyongbum Henry Kim
Hyongbum Henry Kim

1 January 2017 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
SLSeungho Lee
Seungho Lee
SCSeohee Choi
Seohee Choi
SKSang Yong Kim
Sang Yong Kim
MYMijin Yun
Mijin Yun
HKHyoungil Kim
Hyoungil Kim
Lee S, et al. J Gastric Cancer. 2017 Dec;17(4):384-393. https://doi.org/10.5230/jgc.2017.17.e43

1 June 2004 in Journal of Natural Products
Verified
Journal Article
Closed access
SLSeung-Ho Lee
Seung-Ho Lee
TTTakashi Tanaka
Takashi Tanaka
GNGen-Ichiro Nonaka
Gen-Ichiro Nonaka
INItsuo Nishioka
Itsuo Nishioka

1 January 2026 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
SLSeungho Lee
Seungho Lee
YRYun Ho Roh
Yun Ho Roh
HSHo-Jung Shin
Ho-Jung Shin
JSJeong Ho Song
Jeong Ho Song
SKSung Eun Kim
Sung Eun Kim
HKHyoungil Kim
Hyoungil Kim
Lee S, et al. J Gastric Cancer. 2026 ;26:e40. https://doi.org/10.5230/jgc.2026.26.e40

1 August 2026 in Korean Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
JYJaeun Yoo
Jaeun Yoo
HKHyun Myong Kim
Hyun Myong Kim
KJKyoungyun Jeong
Kyoungyun Jeong
YYYie-Ri Yoo
Yie-Ri Yoo
JSJi-Yeon Shin
Ji-Yeon Shin
HYHan-Kwang Yang
Han-Kwang Yang
Purpose: Gastric cancer is a major global health issue, especially in advanced stages with metastasis. However, anti-angiogenic treatments such as ramucirumab target vascular endothelial growth factor, yet the exact mechanisms behind hematogenous metastasis remain unclear. This study analyzed RNA sequencing data from TCGA to identify angiogenesis-related genes in metastatic gastric cancer.Methods: Patients were categorized into four metastasis types (non-metastasis, hematogenous, locoregional, and lymphatic) based on clinical data. cBioPortal was used to identify frequently mutated genes across five metastatic cancer studies. RNA sequencing and clinical data were obtained from the TCGA-STAD project. RNA expression levels were compared across metastasis groups using independent-samples t-tests, followed by false discovery rate adjustment for multiple comparisons.Results: RNA expression analysis was performed using a 132-gene analytical panel in the TCGA-STAD cohort. Among the 95-gene angiogenesis/metastasis-related genes represented in this panel, RAF1, ARID1A, ERBB3, FGFR3, BAP1, TSC2, and KDR showed nominal expression differences in comparisons involving the hematogenous metastasis group. None of these differences remained statistically significant after false discovery rate correction.Conclusion: In this exploratory analysis, several candidate genes with prior literature support showed nominal expression differences in comparisons involving hematogenous metastasis in gastric cancer. These findings are hypothesis-generating and require validation in independent cohorts and functional studies.